Earnings Winners & Losers: IVD Big Hitters Roche, TMO, DHR, DGX, QGEN,
Executive Summary
Medtech Insight highlights results from some of the leading IVD players. This week we spotlight Thermo Fisher Scientific, Danaher, Qiagen and Quest Diagnostics. But which among them are this season's earnings winners and losers?
You may also be interested in...
GE And Roche Join Forces In First-Of-Its-Kind Tech Pact
The goliaths of imaging and in vitro diagnostics have sealed a pact to codevelop a new data analytics platform for faster clinical decision-making, more accurate diagnosis and more personalized treatments.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.